FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bart Haagmans

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Disorders

Concepts & Ideas

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Werner J D Ouwendijk; Geert van Amerongen; Rik de Swart; Sarah Getu; Don Gilden; Bart L Haagmans; Ravi Mahalingam; Albert D M E Osterhaus; Georges M G M Verjans
T-Cell Tropism of Simian Varicella Virus during Primary Infection.
V Stalin Raj; Peter J M Rottier; Saskia L Smits; Volker Thiel; Ali Zaki; Berend Jan Bosch; Dick H W Dekkers; Jeroen A A Demmers; Ronald Dijkman; Christian Drosten; Ron A M Fouchier; Huihui Mou; Marcel Alexander Müller; Doreen Muth; Albert D M E Osterhaus; Bart L Haagmans
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
Martin T Ferris; Lisa E Gralinski; Bart L Haagmans; Lauri D Aicher; David L Aylor; Ralph S Baric; Timothy A Bell; Daniel Bottomly; Birgit Bradel-Tretheway; Janine T Bryan; Ryan J Buus; Gary A Churchill; Michael G Katze; Leonard McMillan; Shannon McWeeney; Darla R Miller; Fernando Pardo-Manuel de Villena; Elizabeth Rosenzweig; David W Threadgill; William Valdar; Jeremy Wang; Alan C Whitmore; Mark T Heise
Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bart Haagmans (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Werner J D Ouwendijk; Geert van Amerongen; Rik de Swart; Sarah Getu; Don Gilden; Bart L Haagmans; Ravi Mahalingam; Albert D M E Osterhaus; Georges M G M Verjans
T-Cell Tropism of Simian Varicella Virus during Primary Infection.
PLoS pathogens 2013;9(5):e1003368.
2013: V Stalin Raj; Peter J M Rottier; Saskia L Smits; Volker Thiel; Ali Zaki; Berend Jan Bosch; Dick H W Dekkers; Jeroen A A Demmers; Ronald Dijkman; Christian Drosten; Ron A M Fouchier; Huihui Mou; Marcel Alexander Müller; Doreen Muth; Albert D M E Osterhaus; Bart L Haagmans
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
Nature 2013;495(7440):251-4.
2013: Martin T Ferris; Lisa E Gralinski; Bart L Haagmans; Lauri D Aicher; David L Aylor; Ralph S Baric; Timothy A Bell; Daniel Bottomly; Birgit Bradel-Tretheway; Janine T Bryan; Ryan J Buus; Gary A Churchill; Michael G Katze; Leonard McMillan; Shannon McWeeney; Darla R Miller; Fernando Pardo-Manuel de Villena; Elizabeth Rosenzweig; David W Threadgill; William Valdar; Jeremy Wang; Alan C Whitmore; Mark T Heise
Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.
PLoS pathogens 2013;9(2):e1003196.
2013: Jonas Söderholm; Jesper Waldenström; Rune Wejstål; Johan Westin; Stefan Zeuzem; Galia Askarieh; Pierre-Yves Bochud; Carlo Ferrari; Bart L Haagmans; Kristoffer Hellstrand; Magnus Lindh; Gabriele Missale; Francesco Negro; Avidan U Neumann; Gunnar Norkrans; Jean-Michel Pawlotsky; Massimo Pilli; Martin Lagging
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.
PloS one 2013;8(2):e56991.
2013: Suzan D Pas; S Rebers; Janke Schinkel; C Copra; Robert J de Knegt; Bart L Haagmans; R Molenkamp; S Seven-Deniz; D Thamke; Martin Schutten
Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
Journal of clinical microbiology 2013;51(1):238-42.
2012: Saskia L Smits; Marije van Leeuwen; Rogier Bodewes; Bart L Haagmans; Claudia M E Schapendonk; Anita C Schürch; Albert D M E Osterhaus
Picobirnaviruses in the human respiratory tract.
Emerging infectious diseases 2012;18(9):1539-40.
2012: V Stalin Raj; Saskia L Smits; Hanneke Moorman-Roest; Albert D M E Osterhaus; Suzan D Pas; Lisette B V Provacia; Bart L Haagmans
Novel hepatitis E virus in ferrets, the Netherlands.
Emerging infectious diseases 2012;18(8):1369-70.
2012: Saskia L Smits; Marije van Leeuwen; Mustafizur Rahman; Claudia M E Schapendonk; Hubert P Endtz; Abu S G Faruque; Bart L Haagmans; Albert D M E Osterhaus
Calicivirus from novel Recovirus genogroup in human diarrhea, Bangladesh.
Emerging infectious diseases 2012;18(7):1192-5.
2012: Daniel Bottomly; Birgit G Bradel-Tretheway; Janine T Bryan; Fernando Pardo-Manuel de Villena; Martin T Ferris; Lisa E Gralinski; Bart L Haagmans; Mark Heise; Michael G Katze; Lauri D Aicher; David L Aylor; Ralph S Baric; Elizabeth Rosenzweig; David W Threadgill; Alan Whitmore; Shannon K McWeeney
Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice.
G3 (Bethesda, Md.) 2012;2(2):213-21.
2012: Judith van den Brand; Marije van Leeuwen; Bart L Haagmans; Albert D M E Osterhaus; Claudia M Schapendonk; James H Simon; Saskia L Smits
Metagenomic analysis of the viral flora of pine marten and European badger feces.
Journal of virology 2012;86(4):2360-5.
2012: Marcel Alexander Müller; Doreen Muth; Albert D M E Osterhaus; V Stalin Raj; Saskia L Smits; Sabine Specht; Tasnim Suliman; Marco Tschapka; Robert Wollny; Ali M Zaki; Katrin Zimmermann; Isabella Eckerle; Ron A M Fouchier; Bart L Haagmans; Stephan Kallies; Benjamin Meyer; Theo M Bestebroer; Tabea Binger; Christian Drosten
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.
mBio 2012;3(6):.
2012: Sander van Boheemen; Ali Moh Zaki; Theo M Bestebroer; Miranda de Graaf; Alexander E Gorbalenya; Bart L Haagmans; Chris Lauber; Albert D M E Osterhaus; V Stalin Raj; Eric J Snijder; Ron A M Fouchier
Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans.
mBio 2012;3(6):.
2012: Åsa Alsiö; Mads Rauning Buhl; Galia Askarieh; Peer Brehm Christensen; Martti Färkkilä; Bart L Haagmans; Kristoffer Hellstrand; Nina Langeland; Kristine Mørch; Salmir Nasic; Gunnar Norkrans; Court Pedersen; Karolina Rembeck; Johan Westin; Martin Lagging
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3.
PloS one 2012;7(5):e37521.
2012: Robert Roomer; Anneke J van Vuuren; Sonja Kwadijk-de Gijsel; Jilling F Bergmann; Andre Boonstra; Robert J de Knegt; Bart L Haagmans; Bettina E Hansen; Harry L A Janssen
Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients.
Antiviral therapy 2012;17(3):509-17.
2011: P-Y Bochud; Carlo Ferrari; Bart L Haagmans; Kristoffer Hellstrand; Gabriele Missale; Francesco Negro; Avidan U Neumann; Jean-Michel Pawlotsky; S Schalm; A Soulier; Stefan Zeuzem; Stephanie Bibert; Martin Lagging
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
Journal of hepatology 2011;55(5):980-8.
2011: Alison A Murphy; Anu O Osinusi; Tje L Chung; Bart L Haagmans; Eva Herrmann; Shyam Kottilil; Richard A Lempicki; William Sachau; Brad J Wood; Lynn Wu; Jun Yang; Tei L Chung; Michael A Polis
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy.
AIDS (London, England) 2011;25(9):1179-87.
2011: Saskia L Smits; Judith van den Brand; Anna de Lang; Lonneke M E Leijten; Wilfred F van Ijcken; Geert van Amerongen; Albert D M E Osterhaus; Arno C Andeweg; Bart L Haagmans
Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species.
Journal of virology 2011;85(9):4234-45.
2011: Byron E E Martina; Petra van den Doel; Penelope Koraka; Geert van Amerongen; Gunther Spohn; Bart L Haagmans; Lisette B V Provacia; Albert D M E Osterhaus; Guus F Rimmelzwaan
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.
PloS one 2011;6(4):e18995.
2011: Martin Lagging; Galia Askarieh; Francesco Negro; Stephanie Bibert; Jonas Söderholm; Johan Westin; Magnus Lindh; Ana Romero; Gabriele Missale; Carlo Ferrari; Avidan U Neumann; Jean-Michel Pawlotsky; Bart L Haagmans; Stefan Zeuzem; Pierre-Yves Bochud; Kristoffer Hellstrand
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.
PloS one 2011;6(2):e17232.
2010: Harel Dahari; Evaldo S Affonso de Araujo; Bart L Haagmans; Thomas J Layden; Scott J Cotler; Antonio A Barone; Avidan U Neumann
Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes.
Journal of hepatology 2010;53(3):460-7.
2010: Asa Alsiö; Peer Brehm Christensen; Martti Färkkilä; Nina Langeland; Mads Rauning Buhl; Court Pedersen; Kristine Mørch; Bart L Haagmans; Johan Westin; Kristoffer Hellstrand; Gunnar Norkrans; Martin Lagging
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(4):e22-5.
2010: Saskia L Smits; Anna de Lang; Judith van den Brand; Lonneke M Leijten; Wilfred F van IJcken; Marinus J C Eijkemans; Geert van Amerongen; Thijs Kuiken; Arno C Andeweg; Albert D M E Osterhaus; Bart L Haagmans
Exacerbated innate host response to SARS-CoV in aged non-human primates.
PLoS pathogens 2010;6(2):e1000756.
2009: Lynn Rozenberg; Bart L Haagmans; Avidan U Neumann; Grace Chen; Mary McLaughlin; Rachel S Levy-Drummer; Henry Masur; Robin L Dewar; Peter Ferenci; Marcelo Silva; Maria S Viola; Michael A Polis; Shyam Kottilil
Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics.
AIDS (London, England) 2009;23(18):2439-50.
2009: Bart L Haagmans; Arno C Andeweg; Albert D M E Osterhaus
The application of genomics to emerging zoonotic viral diseases.
PLoS pathogens 2009;5(10):e1000557.
2008: Arno C Andeweg; Bart L Haagmans; Albert Dme Osterhaus
Virogenomics: the virus-host interaction revisited.
Current opinion in microbiology 2008;11(5):461-6.
2008: Judith van den Brand; Bart L Haagmans; L Leijten; Debby van Riel; Byron Martina; A D M E Osterhaus; Thijs Kuiken
Pathology of experimental SARS coronavirus infection in cats and ferrets.
Veterinary pathology 2008;45(4):551-62.
2008: Byron Martina; Penelope Koraka; Petra van den Doel; Guus F Rimmelzwaan; Bart L Haagmans; Albert D M E Osterhaus
DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
Virus research 2008;135(1):64-71.
2008: Martijn J ter Borg; Bettina E Hansen; G Bigot; Bart L Haagmans; Harry L A Janssen
ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2008;42(2):160-4.
2008: Suwanna Noppornpanth; yong poovorawan; Truong Xuan Lien; Saskia L Smits; Albert D M E Osterhaus; Bart L Haagmans
Complete genome analysis of hepatitis C virus subtypes 6t and 6u.
The Journal of general virology 2008;89(Pt 5):1276-81.
2007: Suwanna Noppornpanth; Saskia L Smits; Truong Xuan Lien; yong poovorawan; Albert D M E Osterhaus; Bart L Haagmans
Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients.
Journal of virology 2007;81(22):12496-503.
2007: Massimo Pilli; Alessandro Zerbini; Amalia Penna; Alessandra Orlandini; Esther Lukasiewicz; Jean-Michel Pawlotsky; Stefan Zeuzem; Solko W Schalm; Michael von Wagner; Georgios Germanidis; Yoav Lurie; Juan I Esteban; Bart L Haagmans; Christophe Hezode; Martin Lagging; Francesco Negro; Yonit Homburger; Avidan U Neumann; Carlo Ferrari; Gabriele Missale
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
Gastroenterology 2007;133(4):1132-43.
2007: Anna de Lang; Tracey Baas; Thomas Teal; Lonneke M Leijten; Brandon Rain; Albert D Osterhaus; Bart L Haagmans; Michael G Katze
Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques.
PLoS pathogens 2007;3(8):e112.
2007: Martijn J ter Borg; Bettina E Hansen; Eva Herrmann; Stefan Zeuzem; YILMAZ CAKALOGLU; Selim Karayalcin; Robert Flisiak; Annemarie van' t Veen; Robert A de Man; Solko W Schalm; Harry La Janssen; Bart L Haagmans
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
Antiviral therapy 2007;12(8):1285-94.
2007: Dave Sprengers; Jeroen N Stoop; Rekha S Binda; Johannes G Kusters; Bart L Haagmans; Patrizia Carotenuto; Andre Artsen; Renate G van der Molen; Harry L Janssen
Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B.
Antiviral therapy 2007;12(7):1087-96.
2006: Martin Lagging; Ana I Romero; Johan Westin; Gunnar Norkrans; Amar P Dhillon; Jean-Michel Pawlotsky; Stefan Zeuzem; Michael von Wagner; Francesco Negro; Solko W Schalm; Bart L Haagmans; Carlo Ferrari; Gabriele Missale; Avidan U Neumann; Elke Verheij-Hart; Kristoffer Hellstrand
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
Hepatology (Baltimore, Md.) 2006;44(6):1617-25.
2006: Scot Henry; Herold J Metselaar; Richard C B Lonsdale; Alice Kok; Bart L Haagmans; Hugo W Tilanus; Luc J van der Laan
Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.
Gastroenterology 2006;131(5):1452-62.
2006: Suwanna Noppornpanth; Erwin Sablon; Kathy De Nys; Xuan Lien Truong; Jan Brouwer; Marianne Van Brussel; Saskia L Smits; yong poovorawan; Albert D M E Osterhaus; Bart L Haagmans
Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions.
Journal of clinical microbiology 2006;44(11):3969-74.
2006: Ana I Romero; Martin Lagging; Johan Westin; Amar P Dhillon; Lynn B Dustin; Jean-Michel Pawlotsky; Avidan U Neumann; Carlo Ferrari; Gabriele Missale; Bart L Haagmans; Solko W Schalm; Stefan Zeuzem; Francesco Negro; Elke Verheij-Hart; Kristoffer Hellstrand
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
The Journal of infectious diseases 2006;194(7):895-903.
2006: Anna de Lang; Albert D M E Osterhaus; Bart L Haagmans
Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells.
Virology 2006;353(2):474-81.
2006: Martijn J ter Borg; Monika van Zonneveld; Stefan Zeuzem; Hakan Senturk; Ulus Akarca; Christopher Simon; Bettina E Hansen; Bart L Haagmans; Robert A de Man; Solko W Schalm; Harry L A Janssen
Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: relation to treatment response.
Hepatology (Baltimore, Md.) 2006;44(3):721-7.
2006: Bart L Haagmans; Albert D M E Osterhaus
Coronaviruses and their therapy.
Antiviral research 2006;71(2-3):397-403.
2006: Suwanna Noppornpanth; Truong Xuan Lien; yong poovorawan; Saskia L Smits; Albert D M E Osterhaus; Bart L Haagmans
Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.
Journal of virology 2006;80(15):7569-77.
2006: Bart L Haagmans; Albert D M E Osterhaus
Nonhuman primate models for SARS.
PLoS medicine 2006;3(5):e194.
2006: Annemiek A van der Eijk; Jan M Vrolijk; Bart L Haagmans
Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C.
The New England journal of medicine 2006;354(12):1323-4.
2005: R R M van der Linden; Bart L Haagmans; P Mongiat-Artus; G J van Doornum; Robert Kraaij; Dov Kadmon; Estuardo Aguilar-Cordova; A D M E Osterhaus; Theo Van der Kwast; Chris H Bangma
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer.
European urology 2005;48(1):153-61.
2005: Marel C de Wit; Marian C Horzinek; Bart L Haagmans; Virgil E J C Schijns
Immunisation with virion-loaded plasmacytoid or myeloid dendritic cells induces primary Th-1 immune responses.
Vaccine 2005;23(11):1343-50.
2004: Jan M Vrolijk; Thjon J Tang; Jaap Kwekkeboom; Bart L Haagmans; A J Herscheid; Johannes G Kusters; Harry L A Janssen; Johannes T Brouwer; Solko W Schalm
Monitoring intrahepatic CD8+ T cells by fine-needle aspiration cytology in chronic hepatitis C infection.
Journal of viral hepatitis 2004;11(4):342-8.
2004: Jan ter Meulen; Alexander B H Bakker; Edward N van den Brink; Gerrit Jan Weverling; Byron Martina; Bart L Haagmans; Thijs Kuiken; John de Kruif; Wolfgang Preiser; Willy Spaan; Hans R Gelderblom; Jaap Goudsmit; Albert D M E Osterhaus
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.
Lancet 2004;363(9427):2139-41.
2004: Marel C de Wit; Marian C Horzinek; Bart L Haagmans; Virgil E J C Schijns
Host-dependent type 1 cytokine responses driven by inactivated viruses may fail to default in the absence of IL-12 or IFN-alpha/beta.
The Journal of general virology 2004;85(Pt 4):795-803.
2004: Bart L Haagmans; Thijs Kuiken; Byron Martina; Ron A M Fouchier; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Ton de Jong; Shigeyuki Itamura; Kwok-Hung Chan; Masato Tashiro; Albert D M E Osterhaus
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
Nature medicine 2004;10(3):290-3.
2003: Jan M Vrolijk; Jaap Kwekkeboom; Harry L A Janssen; Bettina E Hansen; pieter zondervan; Albert D M E Osterhaus; Solko W Schalm; Bart L Haagmans
Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection.
The Journal of infectious diseases 2003;188(10):1528-32.
2003: Byron Martina; Bart L Haagmans; Thijs Kuiken; Ron A M Fouchier; Guus F Rimmelzwaan; Geert van Amerongen; J S M Peiris; Wilina Lim; Albert D M E Osterhaus
Virology: SARS virus infection of cats and ferrets.
Nature 2003;425(6961):915.
2003: Cornelis de Haan; Marèl de Wit; Lili Kuo; Cynthia Montalto-Morrison; Bart L Haagmans; Susan R Weiss; Paul S Masters; Peter J M Rottier
The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain.
Virology 2003;312(2):395-406.
2003: Jan M Vrolijk; Artur Kaul; Bettina E Hansen; Volker Lohmann; Bart L Haagmans; Solko W Schalm; Ralf Bartenschlager
A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.
Journal of virological methods 2003;110(2):201-9.
2003: Teeraporn Chinchai; Joost Labout; Suwanna Noppornpanth; Apiradee Theamboonlers; Bart L Haagmans; Albert D M E Osterhaus; yong poovorawan
Comparative study of different methods to genotype hepatitis C virus type 6 variants.
Journal of virological methods 2003;109(2):195-201.
2003: Bart L Haagmans; Jos W Hoogerbrugge; Axel P N Themmen; Katja J Teerds
Rat testicular germ cells and Sertoli cells release different types of bioactive transforming growth factor beta in vitro.
Reproductive biology and endocrinology : RB&E 2003;1():3.
2003: Suwanna Noppornpanth; Bart L Haagmans; Parvapan Bhattarakosol; Parntep Ratanakorn; Hubert G M Niesters; Albert D M E Osterhaus; yong poovorawan
Molecular epidemiology of gibbon hepatitis B virus transmission.
The Journal of general virology 2003;84(Pt 1):147-55.
2002: Viroj Verachai; Tipwan Phutiprawan; Apiradee Theamboonlers; Teeraporn Chinchai; Srivilai Tanprasert; Bart L Haagmans; Albert D M E Osterhaus; yong poovorawan
Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
The Southeast Asian journal of tropical medicine and public health 2002;33(4):849-51.
2002: E M A van Rooij; Harrie L Glansbeek; Luuk A T Hilgers; Eddie G te Lintelo; Yolanda E de Visser; W J A Boersma; Bart L Haagmans; A T J Bianchi
Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.
Journal of virology 2002;76(20):10540-5.
2002: Harrie L Glansbeek; Bart L Haagmans; Eddie G te Lintelo; Herman F Egberink; Véronique Duquesne; André Aubert; Marian C Horzinek; Peter J M Rottier
Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus.
The Journal of general virology 2002;83(Pt 1):1-10.
2000: E M A van Rooij; Bart L Haagmans; Harrie L Glansbeek; Yolanda E de Visser; M G M de Bruin; W J A Boersma; A T J Bianchi
A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection.
Veterinary immunology and immunopathology 2000;74(1-2):121-36.
1999: Bart L Haagmans; E M A van Rooij; M Dubelaar; Tjeerd G Kimman; Marian C Horzinek; Virgil E J C Schijns; A T J Bianchi
Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D.
Vaccine 1999;17(9-10):1264-71.
1998: E M A van Rooij; Bart L Haagmans; Yolanda E de Visser; M G M de Bruin; W J A Boersma; A T J Bianchi
Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs.
Veterinary immunology and immunopathology 1998;66(2):113-26.
1998: Virgil E J C Schijns; Bart L Haagmans; CM Wierda; B Kruithof; I A Heijnen; G Alber; Marian C Horzinek
Mice lacking IL-12 develop polarized Th1 cells during viral infection.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(8):3958-64.
1997: AA Herrewegh; Michael Mähler; Hans J Hedrich; Bart L Haagmans; Herman F Egberink; Marian C Horzinek; Peter J M Rottier; Raoul J de Groot
Persistence and evolution of feline coronavirus in a closed cat-breeding colony.
Virology 1997;234(2):349-63.
1997: Bart L Haagmans; Katja J Teerds; A J van den Eijnden-van Raaij; Marian C Horzinek; Virgil E J C Schijns
Transforming growth factor beta production during rat cytomegalovirus infection.
The Journal of general virology 1997;78 ( Pt 1)():205-13.
1996: Bart L Haagmans; Herman F Egberink; Marian C Horzinek
Apoptosis and T-cell depletion during feline infectious peritonitis.
Journal of virology 1996;70(12):8977-83.
1995: Virgil E J C Schijns; Bart L Haagmans; Marian C Horzinek
IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(5):2525-32.
1994: Virgil E J C Schijns; Bart L Haagmans; E O Rijke; S Huang; M Aguet; Marian C Horzinek
IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(5):2029-37.
1994: Bart L Haagmans; A J van den Eertwegh; E Claassen; Marian C Horzinek; Virgil E J C Schijns
Tumour necrosis factor-alpha production during cytomegalovirus infection in immunosuppressed rats.
The Journal of general virology 1994;75 ( Pt 4)():779-87.
1994: Bart L Haagmans; P H van der Meide; F S Stals; A J van den Eertwegh; E Claassen; C A Bruggeman; Marian C Horzinek; Virgil E J C Schijns
Suppression of rat cytomegalovirus replication by antibodies against gamma interferon.
Journal of virology 1994;68(4):2305-12.
1994: Bart L Haagmans; F S Stals; P H van der Meide; C A Bruggeman; Marian C Horzinek; Virgil E J C Schijns
Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus.
Journal of virology 1994;68(4):2297-304.
1991: Virgil E J C Schijns; R Van der Neut; Bart L Haagmans; D R Bar; H Schellekens; Marian C Horzinek
Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
The Journal of general virology 1991;72 ( Pt 4)():809-15.
1989: Virgil E J C Schijns; Bart L Haagmans; H Schellekens; Marian C Horzinek
Protection of rats against pseudorabies virus infection by gamma-interferon.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1989;192(1):47-55.